Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

ADDvise Group AB (publ) (ADDV-A.ST)

Compare
3.7700
-0.0100
(-0.26%)
At close: April 17 at 9:00:01 AM GMT+2
Loading Chart for ADDV-A.ST
  • Previous Close 3.7800
  • Open 3.7700
  • Bid 3.6400 x --
  • Ask 3.7000 x --
  • Day's Range 3.7700 - 3.7700
  • 52 Week Range 3.1968 - 16.7000
  • Volume 2
  • Avg. Volume 5,128
  • Market Cap (intraday) 477.964M
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 19.84
  • EPS (TTM) 0.1900
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 26, 2021
  • 1y Target Est 13.00

ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies medical equipment, consumables, and pharmaceuticals in areas, such as urology, gynecology, emergency care, and surgery. It is also involved in rental and sale of medical equipment; distributes specialized instruments, consumables, and services in the life-science and biopharma sectors; designing, constructing, and installing customized cleanrooms and air conditioning systems; distributes glucose monitors and insulin pumps for diabetic patients; develops, manufactures, and markets products for rescue, ambulance, healthcare, and rehabilitation operations. In addition, the company offers implants, instruments, and technologies for surgical precision and patient; disposable medical devices, cables, connectors, wires, CO2 indicators, ultrasound device, patient positioning equipment, and surgical tables; develops software and instruments for patient mobility, pain, and muscle strength to rehabilitate muscular conditions, as well as to streamline the monitoring of vital signs in patients in long-term care and nursing homes; operates mail-order pharmacy specializing in men's health medications for treating cancer, incontinence, and impotence; develops, manufactures, and markets over-the-counter generic drugs for pain management and for the treatment of coughs, colds, allergies, sinus infections, and urological conditions; and supplies glucose meter and test strip products. The company was formerly known as ADDvise Lab Solutions AB (publ). ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.

www.addvisegroup.se

641

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ADDV-A.ST

View More

Performance Overview: ADDV-A.ST

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ADDV-A.ST
60.89%
OMX Stockholm 30 Index (^OMX)
5.14%

1-Year Return

ADDV-A.ST
70.66%
OMX Stockholm 30 Index (^OMX)
5.98%

3-Year Return

ADDV-A.ST
48.57%
OMX Stockholm 30 Index (^OMX)
12.55%

5-Year Return

ADDV-A.ST
90.40%
OMX Stockholm 30 Index (^OMX)
53.50%

Compare To: ADDV-A.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ADDV-A.ST

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    439.49M

  • Enterprise Value

    1.90B

  • Trailing P/E

    19.90

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.08

  • Price/Book (mrq)

    1.35

  • Enterprise Value/Revenue

    1.13

  • Enterprise Value/EBITDA

    4.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.36%

  • Return on Assets (ttm)

    5.43%

  • Return on Equity (ttm)

    12.43%

  • Revenue (ttm)

    1.68B

  • Net Income Avi to Common (ttm)

    90M

  • Diluted EPS (ttm)

    0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    355.7M

  • Total Debt/Equity (mrq)

    214.42%

  • Levered Free Cash Flow (ttm)

    -39.26M

Research Analysis: ADDV-A.ST

View More

Company Insights: ADDV-A.ST

Research Reports: ADDV-A.ST

View More

People Also Watch